From Pfizer to Moderna: who’s making billions from Covid-19 vaccines? | Pharmaceuticals industry | The Guardian
The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for some pharmaceutical companies. Among the biggest winners will be Moderna and Pfizer – two very different US pharma firms which are …
